WallStreetZenWallStreetZen

NASDAQ: VBIV
Vbi Vaccines Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VBIV past revenue growth

How has VBIV's revenue growth performed historically?
Company
833.56%
Industry
110.58%
Market
14.02%
VBIV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VBIV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VBIV's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VBIV earnings and revenue history

Current Revenue
$8.1M
Current Earnings
-$114.8M
Current Profit Margin
-1,413.8%

VBIV Return on Equity

Current Company
-333.3%
Current Industry
15.6%
Current Market
-8.4%
VBIV's Return on Equity (-333.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VBIV announces earnings.

VBIV Return on Assets

Current Company
-97.2%
Current Industry
2.2%
VBIV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VBIV Return on Capital Employed

Current Company
-458.14%
Current Industry
17.7%
VBIV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VBIV vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VBIV$8.12M-$106.04M-$114.83M+56.25%N/A
SNSE$0.00-$36.35M-$38.92MN/AN/A
NLSP$0.00-$15.36M-$15.47MN/AN/A
MBRX$0.00-$26.15M-$26.27MN/AN/A
GLTO$0.00-$45.18M-$45.94MN/AN/A
View Top Biotech Stocks

Vbi Vaccines Earnings & Revenue FAQ

What were VBIV's earnings last quarter?

On Invalid Date, Vbi Vaccines (NASDAQ: VBIV) reported Q3 2023 earnings per share (EPS) of -$1.01, up 65.53% year over year. Total Vbi Vaccines earnings for the quarter were -$21.31 million. In the same quarter last year, Vbi Vaccines's earnings per share (EPS) was -$2.93.

If you're new to stock investing, here's how to buy Vbi Vaccines stock.

What was VBIV's earnings growth in the past year?

As of Q4 2023, Vbi Vaccines's earnings has grown year over year. Vbi Vaccines's earnings in the past year totalled -$114.83 million.

What was VBIV's revenue last quarter?

On Invalid Date, Vbi Vaccines (NASDAQ: VBIV) reported Q3 2023 revenue of $6.62 million up 1,989.59% year over year. In the same quarter last year, Vbi Vaccines's revenue was $317.00 thousand.

What was VBIV's revenue growth in the past year?

As of Q4 2023, Vbi Vaccines's revenue has grown 833.56% year over year. This is 722.99 percentage points higher than the US Biotechnology industry revenue growth rate of 110.58%. Vbi Vaccines's revenue in the past year totalled $8.12 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.